Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study Meeting Abstract
| Authors: | Myers, A. P.; Filiaci, V. L.; Zhang, Y. P.; Pearl, M.; Behbakht, K.; Makker, V.; Hanjani, P.; Zweizig, S.; Burke, J. J.; Downey, G.; Leslie, K. K.; Birrer, M. J.; Fleming, G. F. |
| Abstract Title: | Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901259 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.5592 |
| Notes: | Meeting Abstract: 5592 -- Source: Wos |
